Guardant Health, Inc.
Guardant Health, Inc. (GH) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · GH · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
107
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Guardant Health, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
GH insider buying and selling by quarter
GH insider selling · GH insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · GH ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
GH executive sell shares · GH board member insider trading · GH insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 4, 2026 | Krognes Steve E. Director | Sale | 9,294 | $1.23M⚡ | Form 4 |
| Jun 3, 2026 | Joyce Meghan V. Director | Option | 8,803 | $335K | Form 4 |
| Jun 3, 2026 | Joyce Meghan V. Director | Sale | 3,516 | $445K | Form 4 |
| Jun 3, 2026 | Joyce Meghan V. Director | Option | 1,197 | $46K | Form 4 |
| Jun 3, 2026 | Joyce Meghan V. Director | Sale | 5,728 | $728K | Form 4 |
| Jun 3, 2026 | Joyce Meghan V. Director | Sale | 650 | $83K | Form 4 |
| Jun 3, 2026 | Joyce Meghan V. Director | Sale | 106 | $14K | Form 4 |
| May 31, 2026 | Krognes Steve E. Director | Option | 154 | — | Form 4 |
| May 28, 2026 | Hidalgo Medina Manuel Director | Sale | 1,000 | $130K | Form 4 |
| May 27, 2026 | Saia John G. Chief Legal Officer | Sale | 9,994 | $1.25M⚡ | Form 4 |
| May 27, 2026 | Saia John G. Chief Legal Officer | Sale | 6 | $756 | Form 4 |
| May 22, 2026 | Freeman Chris Chief Commercial Officer | Option | 24,406 | $802K | Form 4 |
| May 22, 2026 | Freeman Chris Chief Commercial Officer | Sale | 24,406 | $2.90M⚡ | Form 4 |
| May 20, 2026 | Saia John G. Chief Legal Officer | Sale | 5,632 | $593K | Form 4 |
| May 20, 2026 | Saia John G. Chief Legal Officer | Sale | 7,187 | $767K | Form 4 |
| May 20, 2026 | Saia John G. Chief Legal Officer | Sale | 7,181 | $770K | Form 4 |
| May 20, 2026 | Talasaz AmirAli Co-Chief Executive Officer · Director | Sale | 200 | $20K | Form 4 |
| May 20, 2026 | Talasaz AmirAli Co-Chief Executive Officer · Director | Sale | 900 | $92K | Form 4 |
| May 20, 2026 | Talasaz AmirAli Co-Chief Executive Officer · Director | Sale | 1,366 | $142K | Form 4 |
| May 20, 2026 | Talasaz AmirAli Co-Chief Executive Officer · Director | Sale | 11,919 | $1.25M⚡ | Form 4 |
| May 20, 2026 | Talasaz AmirAli Co-Chief Executive Officer · Director | Sale | 1,200 | $127K | Form 4 |
| May 20, 2026 | Talasaz AmirAli Co-Chief Executive Officer · Director | Sale | 21,171 | $2.27M⚡ | Form 4 |
| May 20, 2026 | Talasaz AmirAli Co-Chief Executive Officer · Director | Sale | 33,069 | $3.57M⚡ | Form 4 |
| May 20, 2026 | Talasaz AmirAli Co-Chief Executive Officer · Director | Sale | 9,852 | $1.07M⚡ | Form 4 |
| May 20, 2026 | Talasaz AmirAli Co-Chief Executive Officer · Director | Sale | 28,908 | $3.18M⚡ | Form 4 |
Saia John G.
Chief Legal Officer
Date
May 27
Shares
9,994
Price
$125.08
Value
$1.25M ⚡
Freeman Chris
Chief Commercial Officer
Date
May 22
Shares
24,406
Price
$32.86
Value
$802K
Freeman Chris
Chief Commercial Officer
Date
May 22
Shares
24,406
Price
$118.67
Value
$2.90M ⚡
Saia John G.
Chief Legal Officer
Date
May 20
Shares
5,632
Price
$105.34
Value
$593K
Saia John G.
Chief Legal Officer
Date
May 20
Shares
7,187
Price
$106.71
Value
$767K
Saia John G.
Chief Legal Officer
Date
May 20
Shares
7,181
Price
$107.23
Value
$770K
Talasaz AmirAli
Co-Chief Executive Officer · Director
Date
May 20
Shares
200
Price
$100.95
Value
$20K
Talasaz AmirAli
Co-Chief Executive Officer · Director
Date
May 20
Shares
900
Price
$102.57
Value
$92K
Talasaz AmirAli
Co-Chief Executive Officer · Director
Date
May 20
Shares
1,366
Price
$103.82
Value
$142K
Talasaz AmirAli
Co-Chief Executive Officer · Director
Date
May 20
Shares
11,919
Price
$105.01
Value
$1.25M ⚡
Talasaz AmirAli
Co-Chief Executive Officer · Director
Date
May 20
Shares
1,200
Price
$105.88
Value
$127K
Talasaz AmirAli
Co-Chief Executive Officer · Director
Date
May 20
Shares
21,171
Price
$106.99
Value
$2.27M ⚡
Talasaz AmirAli
Co-Chief Executive Officer · Director
Date
May 20
Shares
33,069
Price
$108.11
Value
$3.57M ⚡
Talasaz AmirAli
Co-Chief Executive Officer · Director
Date
May 20
Shares
9,852
Price
$108.97
Value
$1.07M ⚡
Talasaz AmirAli
Co-Chief Executive Officer · Director
Date
May 20
Shares
28,908
Price
$110.10
Value
$3.18M ⚡
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About GH insider trading
GH insider trades
Guardant Health, Inc. (GH) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Talasaz AmirAli (Co-Chief Executive Officer · Director), Saia John G. (Chief Legal Officer), Freeman Chris (Chief Commercial Officer). Over the past 12 months, 5 insiders have filed transactions with the SEC. GH insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Guardant Health, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
GH insider trading · 5 questionsThe insiders of Guardant Health, Inc. (GH) include executives and directors such as Talasaz AmirAli (Co-Chief Executive Officer · Director), Saia John G. (Chief Legal Officer), Freeman Chris (Chief Commercial Officer), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026